OncLive.com
@onclive
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
ID: 43051682
http://www.onclive.com 28-05-2009 05:04:27
104,104K Tweet
45,45K Followers
1,1K Following
Tivumecirnon Plus Pembrolizumab Displays Activity and Tolerability in HNSCC Jameel Muzaffar MD Duke Cancer Duke University School of Medicine #hncsm onclive.com/view/tivumecir…